» Articles » PMID: 37903900

Multiparity Increases the Risk of Diabetes by Impairing the Proliferative Capacity of Pancreatic β Cells

Overview
Journal Exp Mol Med
Date 2023 Oct 31
PMID 37903900
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnancy imposes a substantial metabolic burden on women, but little is known about whether or how multiple pregnancies increase the risk of maternal postpartum diabetes. In this study, we assessed the metabolic impact of multiple pregnancies in humans and in a rodent model. Mice that underwent multiple pregnancies had increased adiposity, but their glucose tolerance was initially improved compared to those of age-matched virgin mice. Later, however, insulin resistance developed over time, but insulin secretory function and compensatory pancreatic β cell proliferation were impaired in multiparous mice. The β cells of multiparous mice exhibited aging features, including telomere shortening and increased expression of Cdkn2a. Single-cell RNA-seq analysis revealed that the β cells of multiparous mice exhibited upregulation of stress-related pathways and downregulation of cellular respiration- and oxidative phosphorylation-related pathways. In humans, women who delivered more than three times were more obese, and their plasma glucose concentrations were elevated compared to women who had delivered three or fewer times, as assessed at 2 months postpartum. The disposition index, which is a measure of the insulin secretory function of β cells, decreased when women with higher parity gained body weight after delivery. Taken together, our findings indicate that multiple pregnancies induce cellular stress and aging features in β cells, which impair their proliferative capacity to compensate for insulin resistance.

Citing Articles

Classification and identification of risk factors for type 2 diabetes.

Tang S, Zhao X, An X, Sun W, Kang X, Sun Y World J Diabetes. 2025; 16(2):100371.

PMID: 39959280 PMC: 11718467. DOI: 10.4239/wjd.v16.i2.100371.


Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications.

Lee J, Lee N, Moon J Endocrinol Metab (Seoul). 2025; 40(1):10-25.

PMID: 39844628 PMC: 11898322. DOI: 10.3803/EnM.2024.2264.


Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia.

Lee J, Yoon K Endocrinol Metab (Seoul). 2025; 40(1):57-63.

PMID: 39814030 PMC: 11898318. DOI: 10.3803/EnM.2024.2193.


Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes.

Moon J, Choe H, Lim S J Diabetes Investig. 2024; 15(6):669-683.

PMID: 38676410 PMC: 11143426. DOI: 10.1111/jdi.14221.

References
1.
Banerjee R, Cyphert H, Walker E, Chakravarthy H, Peiris H, Gu X . Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells. Diabetes. 2016; 65(8):2331-41. PMC: 4955982. DOI: 10.2337/db15-1527. View

2.
Nagaraj V, Kazim A, Helgeson J, Lewold C, Barik S, Buda P . Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol. Mol Endocrinol. 2016; 30(10):1059-1069. PMC: 5045496. DOI: 10.1210/me.2016-1023. View

3.
Tsang S, Shao D, Cheah K, Okuse K, Leung P, Yao K . Increased basal insulin secretion in Pdzd2-deficient mice. Mol Cell Endocrinol. 2009; 315(1-2):263-70. DOI: 10.1016/j.mce.2009.11.007. View

4.
OCallaghan N, Fenech M . A quantitative PCR method for measuring absolute telomere length. Biol Proced Online. 2011; 13:3. PMC: 3047434. DOI: 10.1186/1480-9222-13-3. View

5.
Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland J . Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013; 123(3):966-72. PMC: 3582125. DOI: 10.1172/JCI64098. View